Special Issue "Immune Response after Vaccination in Patients with Inflammatory Diseases"
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Innate and Adaptive Immunity in Vaccination".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 56
Special Issue Editors
Prof. Dr. Małgorzata Wisłowska
Interests: the influence of immunomodulatory drugs; biological and synthetic targeted drugs; on immune response
Interests: the impact of immunomodulatory drugs; biological and synthetic targeted drugs; on the immunogenicity of vaccinations in patients with autoimmune inflammatory rheumatic diseases
Special Issue Information
Dear Colleagues,
Patients with autoimmune inflammatory diseases are among immune-incompetent patients. Altered functioning of the immune system and the use of immunomodulatory drugs make this group of patients more vulnerable to infections. The use of vaccines as a preventive measure against selected infectious diseases in patients with autoimmune inflammatory diseases is thus of paramount importance. Unfortunately, the same factors that make these patients more susceptible to infections also influence the post-vaccination response.
This Special Issue aims to feature papers that underscore aspects of the immune response after vaccination in patients with autoimmune inflammatory diseases, focusing on the immunogenicity of vaccines, the impact of immunomodulatory drugs on post-vaccination humoral and cellular responses, immunological mechanisms that influence the response in patients with autoimmune inflammatory diseases, and the translation of this knowledge into clinical practice. We welcome submissions of original research articles (both clinical and translational studies) as well as reviews.
We look forward to receiving your manuscripts.
Prof. Dr. Małgorzata Wisłowska
Guest Editor
Dr. Jakub Wroński
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunogenicity
- cellular response
- humoral response
- vaccines
- autoimmune diseases
- inflammatory diseases
- immunomodulatory treatment
- disease-modifying antirheumatic drugs
- biological drugs
- targeted synthetic drugs
